Skip to main content

Pau Mollá Zaragozá

Institutions of which they are part

Predoctoral researcher
Neuromuscular and Mitochondrial Pathology
Vall Hebron Institut de Recerca

Pau Mollá Zaragozá

Institutions of which they are part

Predoctoral researcher
Neuromuscular and Mitochondrial Pathology
Vall Hebron Institut de Recerca

Projects

Models d'estudi de malalties degudes a manteniment defectuós del DNA mitocondrial

IP: Ramon Martí Seves
Collaborators: Mª Jesus Melia Grimal, Pau Mollá Zaragozá, Javier Francisco Ramón Pasías, Juan Luis Restrepo Vera
Funding agency: Instituto de Salud Carlos III
Funding: 208750
Reference: PI24/00838
Duration: 01/01/2025 - 31/12/2027

x

IP: Laia Perez Lasarte
Collaborators: Pau Mollá Zaragozá, Ramon Martí Seves
Funding agency: Fundació Institut de Recerca HUVH
Funding: 55810.89
Reference: VHIR/PHDPROGRAMME/2022/MOLLA
Duration: 01/06/2022 - 30/09/2025

Related news

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

The newly developed analytical workflow could in the future be introduced as a comprehensive diagnostic test for patients with mitochondrial diseases.

Related professionals

Cendy Gabriela Laínez Laínez

Cendy Gabriela Laínez Laínez

Research technician
Epidemiology and Public Health
Read more
Anna Font Alberich

Anna Font Alberich

Research assistant
Biomedical Research in Gynaecology
Read more
Anabel Montero Armengol

Anabel Montero Armengol

Predoctoral researcher
Biomedical Research in Gynaecology
Read more
Núria Martínez Gil

Núria Martínez Gil

Postdoctoral researcher
Genetics Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.